Curcumin down-regulates CX3CR1 expression in spinal cord dorsal horn and DRG in neuropathic pain rats

Zhongguo Zhongyao Zazhi

Volumn 36, Issue 18, 2011, Pages 2552-2556

  Zheng, Jinwei ^a   Zheng, Changjian ^a   Cao, Hong ^a   Li, Jun ^a   Uan, Qingquan ^a  

^a WENZHOU MEDICAL UNIVERSITY   (China)

Author keywords

Curcumin; CX3CR1 protein; Dorsal root ganglion; Microglia; Neuralgia; Spinal cord

Indexed keywords

CHEMOKINE RECEPTOR CX3CR1; CURCUMIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHRONIC CONSTRICTIVE INJURY; COMPARATIVE STUDY; DOWN REGULATION; MALE; NERVE COMPRESSION; NEUROPATHIC PAIN; NONHUMAN; POSTOPERATIVE PERIOD; PROTEIN EXPRESSION; RAT; SPINAL CORD DORSAL HORN; SPINAL GANGLION;

ANALGESICS; ANIMALS; CURCUMIN; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GANGLIA, SPINAL; INJECTIONS, INTRAPERITONEAL; MALE; NEURALGIA; POSTERIOR HORN CELLS; RANDOM ALLOCATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, CHEMOKINE;

EID: 83055174701     PISSN: 10015302     EISSN: None     Source Type: Journal    
DOI: 10.4268/cjcmm20111822     Document Type: Article

References (16)

1. Costigan M, Scholz J, Woolf C J. Neuro pathic pain: a maladaptive response of the nervous system to damage[J]. Annu Rev Neurosci, 2009, 32: 1.
2. Verge G M, Milligan E D, Maier S F, et al. Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions[J]. Eur J Neurosci, 2004, 20: 1150.
3. Bennett G J, Xie Y K. A peripheral mononeuropathy in rat produces disorders of pain sensation like those seen in man[J]. Pain, 1988, 33: 87.
4. Hu P, Bembrick A L, Keay K A, et al. Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve[J]. Brain Behav Imnmn, 2007, 21: 599.
5. Hanisch U K. Microglia as a source and target of cytokines[J]. Glia, 2002, 40: 140.
6. Raghavendra V, Tanga F, DeLeo J A. Inhibition of microglial activation attenuates the development but not existing hypersensitivity in a rat model of neuropathy[J]. J Pharmacol Exp Ther, 2003, 306: 624.
7. Milligan E D, Zapata V, Chacur M, et al. Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats[J]. Eur J Neurosci, 2004, 20: 2294.
8. Sun S, Cao H, Han M, et al. New evidence for the involvement of spinal fractalkine receptor in pain facilitation and spinal glial activation in rat model of mono-arthritis[J]. Pain, 2007, 129(1/2): 64.
9. Tsuda M, Mizokoshi A, Koizumi S, et al. Activation of p38 mitogen-activated protein kinase in spinal hyperactive microglia contributes to pain hypersensitivity following peripheral nerve injury[J]. Glia, 2004, 45: 89.
10. Zhuang Z Y, Kawasaki Y, Ji R R, et al. Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine[J]. Brain Behav Immun, 2007, 21: 642.
11. O'Rielly D D, Loomis C W. Spinal nerve ligation-induced activation of nuclear factor kappa B is facilitated by prostaglandins in the affected spianl cord and is a critical step in the development of mechanical allodynia[J]. Neuroscience, 2008, 155: 902.
12. Ji R R, Suter M R. p38 MAPK, microglial signaling, and neuropathic pain[J]. Mol Pain, 2007, 3: 33.
13. Aggarwal S, Ichikawa H, Takada Y, et al. Curcumin (diferu-loylmethane) down-regulates ex-pression of cell proliferation and antiapoptotic and metastatic gene products through suppression of IκBα Kinase and Akt activation[J]. Mol Pharmacol, 2006, 69: 195.